Showing posts with label Access and Benefit Sharing. Show all posts
Showing posts with label Access and Benefit Sharing. Show all posts

Monday, December 16, 2013

Draft Trans-Pacific Partnership Treaty – Nagoya Protocol and Genetic Resources

The Nagoya Protocol to the Convention on Biological Diversity has been in the news lately as it is currently on its way to being enacted into European Union legislation (see IPKat posts here and here – and yes, I am the “Norman” who commented on those posts). So I’ve decided to post some observations on the leaked draft TPP treaty proposed provisions dealing with genetic resources, which I drafted in my spate of blogging on the TPP, but never got around to posting at the time.

Understanding these provisions requires some background on the Nagoya Protocol to the Convention on Biological Diversity. The Nagoya Protocol mandates a system in which the benefits of exploitation of genetic resources are shared with the party providing that resource. The basic idea is nothing novel. If company A wants access to a novel organism or compound X owned by company B, A would normally enter into a material transfer agreement with B, which might well require A to pay B royalties on any patented invention derived from X. The Nagoya Protocol contemplates that if company A wants to, for example, go bioprospecting in the Amazon rain forest, it would get prior consent from a competent national authority (Art 13) and enter into an access and benefit sharing (ABS) agreement to share any benefits on mutually agreed terms (Art 5). Traditional knowledge is treated in a similar way. In other words, the effect is that countries would be deemed to own the genetic resources within their territory, and company A seeking to exploit those would contract with the national authority over the terms of access in the same way that it would contract with company B. A great deal of the Nagoya Protocol describes the structure of this contracting process.